EARNEST Partners’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $147M | Buy |
2,829,915
+30,216
| +1% | +$1.57M | 0.66% | 51 |
|
|
2025
Q1 | $169M | Sell |
2,799,699
-10,477
| -0.4% | -$633K | 0.81% | 33 |
|
|
2024
Q4 | $192M | Buy |
2,810,176
+25,876
| +0.9% | +$1.77M | 0.86% | 27 |
|
|
2024
Q3 | $200M | Sell |
2,784,300
-34,306
| -1% | -$2.47M | 0.87% | 29 |
|
|
2024
Q2 | $195M | Buy |
2,818,606
+447,498
| +19% | +$31M | 0.91% | 25 |
|
|
2024
Q1 | $190M | Buy |
2,371,108
+25,411
| +1% | +$2.03M | 0.87% | 29 |
|
|
2023
Q4 | $257M | Buy |
2,345,697
+80,605
| +4% | +$8.83M | 1.28% | 10 |
|
|
2023
Q3 | $228M | Buy |
2,265,092
+44,076
| +2% | +$4.45M | 1.32% | 7 |
|
|
2023
Q2 | $302M | Sell |
2,221,016
-494,873
| -18% | -$67.2M | 1.69% | 5 |
|
|
2023
Q1 | $282M | Buy |
2,715,889
+313,537
| +13% | +$32.6M | 1.63% | 5 |
|
|
2022
Q4 | $213M | Buy |
2,402,352
+335,974
| +16% | +$29.8M | 1.31% | 7 |
|
|
2022
Q3 | $166M | Buy |
2,066,378
+404,586
| +24% | +$32.4M | 1.11% | 16 |
|
|
2022
Q2 | $159M | Buy |
1,661,792
+187,134
| +13% | +$17.9M | 1.06% | 19 |
|
|
2022
Q1 | $219M | Sell |
1,474,658
-44,665
| -3% | -$6.63M | 1.3% | 13 |
|
|
2021
Q4 | $215M | Sell |
1,519,323
-83,807
| -5% | -$11.9M | 1.24% | 18 |
|
|
2021
Q3 | $210M | Sell |
1,603,130
-25,718
| -2% | -$3.36M | 1.28% | 12 |
|
|
2021
Q2 | $224M | Sell |
1,628,848
-7,824
| -0.5% | -$1.08M | 1.32% | 13 |
|
|
2021
Q1 | $214M | Buy |
1,636,672
+61,336
| +4% | +$8.01M | 1.28% | 17 |
|
|
2020
Q4 | $176M | Buy |
1,575,336
+459,191
| +41% | +$51.4M | 1.22% | 16 |
|
|
2020
Q3 | $87.8M | Buy |
+1,116,145
| New | +$87.8M | 0.76% | 51 |
|